1. Home
  2. TARS vs PRK Comparison

TARS vs PRK Comparison

Compare TARS & PRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$60.59

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

PRK

Park National Corporation

HOLD

Current Price

$177.50

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TARS
PRK
Founded
2016
1908
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.1B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
TARS
PRK
Price
$60.59
$177.50
Analyst Decision
Buy
Hold
Analyst Count
6
3
Target Price
$89.00
$184.00
AVG Volume (30 Days)
466.4K
68.2K
Earning Date
05-06-2026
04-24-2026
Dividend Yield
N/A
2.61%
EPS Growth
48.21
19.21
EPS
N/A
2.39
Revenue
$451,360,000.00
$664,421,000.00
Revenue This Year
$56.43
$24.26
Revenue Next Year
$30.19
$3.63
P/E Ratio
N/A
$73.65
Revenue Growth
146.71
2.92
52 Week Low
$38.51
$149.06
52 Week High
$85.25
$182.34

Technical Indicators

Market Signals
Indicator
TARS
PRK
Relative Strength Index (RSI) 46.26 58.96
Support Level $56.90 $168.79
Resistance Level $67.24 N/A
Average True Range (ATR) 2.61 3.57
MACD 0.37 0.67
Stochastic Oscillator 52.62 66.07

Price Performance

Historical Comparison
TARS
PRK

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

About PRK Park National Corporation

Park National Corp is a diversified financial services company based in Newark, Ohio, consisting of 11 community banking divisions with more than 100 offices in Ohio and Kentucky. The company provides the following principal services: the acceptance of deposits for demand, savings and time accounts; commercial, industrial, consumer and real estate lending, including installment loans, credit cards (which are largely offered through a third party), home equity lines of credit and commercial leasing; trust and wealth management services; cash management; safe deposit operations; electronic funds transfers; and a variety of additional banking-related services.

Share on Social Networks: